Phase
Condition
Cancer/tumors
Gliomas
Neurofibromatosis
Treatment
C-SMART
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Confirmed primary brain tumor diagnosis by histology or neuro-oncologist review ofimaging
At least one domain of neurocognitive function >1.5 SD below the average or theindividual's estimated premorbid functioning, using the expanded ICCTF clinicaltrials battery and Test of Premorbid Functioning for comparison
>1 month post brain surgery and/or radiation therapy, if applicable
Estimated premorbid intelligence >75.
Patients must be age 18+ and primarily English speaking
Exclusion
Exclusion Criteria:
Presence of major neurocognitive impairment that would prevent participation in theintervention, and/or severe aphasia, and/or inability to understand and provideinformed consent
Inability to attend weekly telehealth appointments; based on EAB results
Clinically significant insomnia symptoms
< 1 month post brain surgery and/or radiation therapy
Unstable internet connection or an inability to work teleconferencing software.Participants will be supplied an iPad if they do not have an adequate device.
To participate in the fMRI portion of this study participants cannot have any metalin their bodies. For the fMRI subset, participants cannot have metal in their bodyas the MRI scan could cause them harm and if female of childbearing years, theycannot be pregnant as the MRI scan may pose risk to the unborn fetus.
Study Design
Connect with a study center
Virginia Commonwealth University
Richmond, Virginia 23298
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.